| News

Interest from startups in the BaseLaunch healthcare accelerator exceeds expectations

25.07.2017

More than 100 projects from Switzerland and abroad competed for a place in the BaselArea.swiss accelerator program for healthcare startups.

By the closing date of June 30, the BaseLaunch startup accelerator received 112 applications. 77 percent of the projects were from Europe, with a total of 45 percent from Switzerland and 25 projects from the rest of the world. A third of applications involved therapeutics, 20 percent were concerned with diagnostics, and 18 percent with digital healthcare and healthcare services. Other projects focused on therapeutic platforms and services, medtech, and related fields. BaseLaunch offers startups infusions of funds, insight, infrastructure and industry access, and integrates them into one of the most dynamic biotech and healthcare ecosystems in Europe. The accelerator program initiated and operated by BaselArea.swiss aims to attract the next generation of successful healthcare companies by harnessing the unique position of the Basel region as a global life sciences hub. BaseLaunch is backed by healthcare partners Novartis Venture Fund, Johnson & Johnson Innovation and Pfizer. BaseLaunch also collaborates with digitalswitzerland as a healthcare vertical of Kickstart Accelerator.

Positive response to the call for applications
“The number of applicants far exceeded our expectations,” says Alethia de León, Managing Director of BaseLaunch. “We now have the task of selecting up to ten of the most promising projects for the first phase.” A selection committee made up of industry experts will be responsible for the selection process. Ventures accepted for the first phase of the program will receive grants of up to 10,000 Swiss francs beginning in September 2017. They will then have three months to develop their business ideas in close collaboration with the BaseLaunch team and a network of experienced entrepreneurs. Up to three startups will be selected from these companies for the second phase. They will each receive up to 250,000 Swiss francs and the opportunity to generate research data for one year in the laboratory of the Switzerland Innovation Park Basel Area and thereby achieve milestones in their business plan. Experts will also be available to advise and mentor during this time.

For Christof Klöpper, CEO of BaselArea.swiss, the large number of applications from abroad is a sure sign of the Basel region’s international reputation as a world-leading life sciences center. BaselArea.swiss has passed on to BaseLaunch all of its expertise in promoting innovation and investment. “We have many years of experience of networking innovators in the local area and supporting entrepreneurs by identifying suitable partners. BaseLaunch takes full advantage of this expertise, which is particularly valuable to participants from outside the region.”

The selected startups for the first phase will be announced in late summer.

For more information, please visit the BaseLaunch website.

Important dates:

Phase I: September 15 – December 7, 2017

Phase II: January 2 – December 21, 2018

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
Startups from the Basel Area ranked among the best
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Startups from the Basel Area ranked among the best

Startups from the Basel Area have been ranked highly in the TOP 100 Swiss Startup Award by Venturelab. The medtech...

Read More
Roche testing for coronavirus and flu simultaneously
Basel Area Business & Innovation, Innovation, Invest

Roche testing for coronavirus and flu simultaneously

The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that...

Read More
Hengrui Medicine sets up clinical research and development in Basel
Basel Area Business & Innovation, Innovation, Invest

Hengrui Medicine sets up clinical research and development in Basel

The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The European hub for clinical research...

Read More
Polyphor awarded exclusive licensing agreement for China
Basel Area Business & Innovation, Innovation, Invest

Polyphor awarded exclusive licensing agreement for China

The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead...

Read More
New label guarantees that data remains in Switzerland
Basel Area Business & Innovation, Innovation, Invest

New label guarantees that data remains in Switzerland

With the new “swiss hosting” label, the Basel-based company swiss made software Gmbh is guaranteeing that data will not be...

Read More
Coworking in the Basel Area – An Interview with Karin Crisanto
Basel Area Business & Innovation, Switzerland Innovation Park

Coworking in the Basel Area – An Interview with Karin Crisanto

Karin Crisanto recently joined Basel Area Business & Innovation as Head of Innovation Space and Infrastructure. She previously worked for...

Read More
Switzerland ranked in second place globally
Basel Area Business & Innovation, Invest

Switzerland ranked in second place globally

The chemical and pharmaceutical industry of Switzerland has been ranked number two in the world after the USA in terms...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.